Torreya Partners
  • OUR FIRM

  • OUR PEOPLE

  • OUR SERVICES

    • Mergers & Acquisitions
    • Licensing
    • Corporate Finance
    • Strategy & Valuation
    • Restructuring & Bankruptcy
  • TRANSACTIONS

  • CONTACT US


Sandy Zweifach
Principal
sandy.zweifach@torreyapartners.com
(415) 652-4959



Sandy is a Principal at Torreya and is also registered with Financial West Group, Torreya’s financing partner. Sandy brings 17 years of proven experience in investment banking, investing, business development, M&A and management. Prior to Torreya, Sandy was CEO of Pathways Diagnostics, a biomarker development company. Previously, Sandy was CFO of Bay City Capital, a merchant bank specializing in the life science industry, and was responsible for oversight of the firm's finance department as well as President of the firm's M&A and financing division. Formerly, Sandy was President and CFO of Epoch Biosciences (acquired by Nanogen), a Certified Public Accountant for Coopers & Lybrand, and held various investment banking positions focusing on biotech. Sandy received his B.A. in Biology from UC San Diego and holds an M.S. in Human Physiology from UC Davis.

Selected Transaction Experience:
•  ARIUS Research, Sale to Roche, $189 million (2008)
•  AVANIR Pharmaceuticals, Sale of FazaClo to Azur Pharma, $54 million (2007)
•  Bioren, Sale to Pfizer, $38 million (2005)
•  Triax Holdings, Debt Financing, $77 million (2005)
•  Pathway Diagnostics, Alliance with Nanogen (2005)
•  Maxia, Sale to Incyte Pharmaceuticals, $42 million (2003)
•  Epoch Biosciences, Private Equity Financings (2000 and 2004)
•  NeoRx, Sale of Stent IP to Boston Scientific (1999)
•  Microprobe, Sale of Diagnostics Business to Becton Dickenson (1997)
•  Private Financings / Investment Structuring for Bay City Capital portfolio of over 40 Companies including Reliant, Pharmion, Medarex, Chemdex, Bioren, Lexicon Genetics, Galileo (1997-2003)
•  Founding Capital Investment Structuring and Private Equity Capital Raises for Alexion, Ariad, Incyte Pharmaceuticals, GeneMedicine, Neurocrine Biosciences, Cell Therapeutics, Hemasure, Biosepra, Biotechnology General, Pharmos


Copyright © 2010 Torreya Partners LLC. All rights reserved.
Home | Sector Focus | Login
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.